Display options
Cite
Pinedo-Villanueva R, Charokopou M, Toth E, et al. Imminent fracture risk assessments in the UK FLS setting: implications and challenges. Arch Osteoporos. 2019;14(1):12doi: 10.1007/s11657-019-0569-2.
Pinedo-Villanueva, R., Charokopou, M., Toth, E., Donnelly, K., Cooper, C., Prieto-Alhambra, D., Libanati, C., & Javaid, M. K. (2019). Imminent fracture risk assessments in the UK FLS setting: implications and challenges. Archives of osteoporosis, 14(1), 12. https://doi.org/10.1007/s11657-019-0569-2
Pinedo-Villanueva, Rafael, et al. "Imminent fracture risk assessments in the UK FLS setting: implications and challenges." Archives of osteoporosis vol. 14,1 (2019): 12. doi: https://doi.org/10.1007/s11657-019-0569-2
Pinedo-Villanueva R, Charokopou M, Toth E, Donnelly K, Cooper C, Prieto-Alhambra D, Libanati C, Javaid MK. Imminent fracture risk assessments in the UK FLS setting: implications and challenges. Arch Osteoporos. 2019 Feb 02;14(1):12. doi: 10.1007/s11657-019-0569-2. PMID: 30712158; PMCID: PMC6398567.
Copy Download .nbib Format: NLM
Share it on

Arch Osteoporos. 2019 Feb 02;14(1):12. doi: 10.1007/s11657-019-0569-2.

Imminent fracture risk assessments in the UK FLS setting: implications and challenges.

Archives of osteoporosis

Rafael Pinedo-Villanueva, Mata Charokopou, Emese Toth, Kerry Donnelly, Cyrus Cooper, Daniel Prieto-Alhambra, Cesar Libanati, Muhammad K Javaid

Affiliations

  1. Nuffield Department of Orthopaedics, Rheumatology and Orthopaedic Sciences, University of Oxford, Oxford, UK.
  2. UCB BioPharma SPRL, Brussels, Belgium.
  3. MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
  4. Nuffield Department of Orthopaedics, Rheumatology and Orthopaedic Sciences, University of Oxford, Oxford, UK. [email protected].

PMID: 30712158 PMCID: PMC6398567 DOI: 10.1007/s11657-019-0569-2

[No abstract available.]

References

  1. Ann Rheum Dis. 2009 Jan;68(1):99-102 - PubMed
  2. JAMA. 2007 Jan 24;297(4):387-94 - PubMed
  3. Osteoporos Int. 2017 Mar;28(3):775-780 - PubMed
  4. Osteoporos Int. 2015 Jul;26(7):1919-28 - PubMed
  5. JAMA. 1999 Oct 13;282(14):1344-52 - PubMed
  6. Osteoporos Int. 2019 Jan;30(1):3-44 - PubMed
  7. Bone. 2004 Aug;35(2):375-82 - PubMed
  8. Osteoporos Int. 2016 Dec;27(12):3439-3447 - PubMed
  9. Lancet. 1996 Dec 7;348(9041):1535-41 - PubMed
  10. Bone Joint J. 2015 Mar;97-B(3):372-82 - PubMed
  11. Osteoporos Int. 2008 Apr;19(4):385-97 - PubMed
  12. J Bone Miner Res. 2000 Apr;15(4):721-39 - PubMed
  13. Osteoporos Int. 2006;17(3):348-54 - PubMed
  14. Arch Osteoporos. 2016 Dec;11(1):26 - PubMed
  15. Osteoporos Int. 2017 Sep;28(9):2565-2571 - PubMed
  16. Osteoporos Int. 2003 Apr;14(2):130-6 - PubMed
  17. Aging Clin Exp Res. 2016 Aug;28(4):797-803 - PubMed
  18. J Clin Endocrinol Metab. 2013 Mar;98(3):946-53 - PubMed
  19. J Bone Miner Res. 2017 Jan;32(1):3-10 - PubMed
  20. J Clin Endocrinol Metab. 2014 Jul;99(7):2599-607 - PubMed
  21. Lancet. 2018 Jan 20;391(10117):230-240 - PubMed
  22. BMJ. 2011 Jun 22;342:d3651 - PubMed
  23. Osteoporos Int. 2013 Aug;24(8):2135-52 - PubMed
  24. Osteoporos Int. 2017 Jun;28(6):1765-1769 - PubMed
  25. Osteoporos Int. 2015 Nov;26(11):2573-8 - PubMed
  26. Osteoporos Int. 2018 Aug;29(8):1747-1757 - PubMed
  27. Arch Osteoporos. 2016 Dec;11(1):37 - PubMed
  28. Osteoporos Int. 2008 Oct;19(10):1431-44 - PubMed
  29. J Bone Miner Res. 2012 Oct;27(10):2039-46 - PubMed
  30. Osteoporos Int. 2011 Jul;22(7):2051-65 - PubMed
  31. Ann Rheum Dis. 2017 May;76(5):802-810 - PubMed
  32. J Clin Endocrinol Metab. 2014 Jul;99(7):2400-8 - PubMed
  33. Osteoporos Int. 2016 Jul;27(7):2207-2215 - PubMed
  34. J Bone Miner Res. 2018 May;33(5):783-794 - PubMed
  35. N Engl J Med. 2017 Oct 12;377(15):1417-1427 - PubMed
  36. J Bone Miner Metab. 2012 Sep;30(5):493-503 - PubMed

Publication Types

Grant support